These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8907903)

  • 41. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microchimerism and graft acceptance: split tolerance in skin and cardiac transplantation with minor histocompatibility antigen H-Y differences.
    Suzuki H; Hara MH; Yamashita A; Miyamoto M; Shibata K; Koga Y; Iwaya M; Yokoi Y; Yamaguchi A; Masaki Y; Li XK; Suzuki S; Amemiya H; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1262-3. PubMed ID: 8658651
    [No Abstract]   [Full Text] [Related]  

  • 43. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanisms of human cardiac allograft rejection: absence of co-stimulatory molecules and cell adhesion molecules on major histocompatibility complex class I/II+ human cardiac myocytes does not induce anergy.
    Sundstrom JB; Mayne A; Kanter K; Herskowitz A; Ansari AA
    Transplant Proc; 1995 Feb; 27(1):1310-3. PubMed ID: 7878895
    [No Abstract]   [Full Text] [Related]  

  • 45. Changes in spontaneous leukocyte blastogenesis during cardiac allograft rejection in rats.
    Koh YB; Yun SS; Moon IS; Lee YK
    Transplant Proc; 1996 Jun; 28(3):1812-3. PubMed ID: 8658894
    [No Abstract]   [Full Text] [Related]  

  • 46. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different mechanisms of rejection of organ and cell allografts.
    Olszewski WL; Jasklowska-Englisz M; Lukomska B
    Transplant Proc; 1996 Dec; 28(6):3444-6. PubMed ID: 8962343
    [No Abstract]   [Full Text] [Related]  

  • 51. The different influences of allosensitization and xenosensitization on cellular rejection.
    Fryer JP; Chen S; Johnson EM; Sun LH; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):674. PubMed ID: 8623338
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3555. PubMed ID: 2662527
    [No Abstract]   [Full Text] [Related]  

  • 53. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of CD30 in skin and heart allograft rejection in the mouse.
    Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
    Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
    [No Abstract]   [Full Text] [Related]  

  • 56. Microchimerism and heart allograft acceptance.
    Masaki Y; Hirasawa A; Okuyama S; Tsujimoto G; Iwaya M; Li XK; Yokoi Y; Nakamura S; Baba S; Miyamoto M
    Transplant Proc; 1995 Feb; 27(1):148-50. PubMed ID: 7878949
    [No Abstract]   [Full Text] [Related]  

  • 57. The induction of class II antigens by interferon-gamma and its relevance for the acute rejection of allografts.
    IJzermans JN; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):244-5. PubMed ID: 3152697
    [No Abstract]   [Full Text] [Related]  

  • 58. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival.
    Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.